Trial Information
Inclusion Criteria:
- Patients with definite diagnosis of HCC based on a Dynamic MRI revealing a vascular
mass in the liver and histologic confirmation of HCC.
- Patients who are not candidates for surgical resection, OLT or radiofrequency
ablation.
- Patients with no prior treatment for HCC.
- Patients with extrahepatic spread and/or vascular invasion are permissible.
Type of Study:
Interventional
Study Design:
Masking: Open Label, Primary Purpose: Treatment
Authority:
United States: Federal Government
Study ID:
NCRR-M01RR00042-1707
NCT ID:
NCT00006332
Start Date:
Completion Date:
Related Keywords:
- Carcinoma, Hepatocellular
- Molybdenum
- Carcinoma
- Carcinoma, Hepatocellular
Name | Location |
3912 Taubman Center |
Ann Arbor, Michigan 48109-0362 |